Search Within

Darragh Fintan Halpenny

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (5)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (11)
  2. Department of Medicine (11)
  3. Department of Pathology and Laboratory Medicine (11)
  4. GSK Faculty (11)
  5. Human Oncology and Pathogenesis Program (11)
  6. Solid Tumor Oncology Division (11)

More Groups

People
  1. Matthew Hellmann (10)
  2. Charles Rudin (9)
  3. Marc Ladanyi (9)
  4. Natasha Rekhtman (7)
  5. Gregory Riely (6)
  6. Mark Kris (6)

More People

Years
  1. 2022 (1)
  2. 2020 (1)
  3. 2019 (4)
  4. 2018 (2)
  5. 2016 (3)
Publications
  1. Journal of Clinical Oncology (3)
  2. Clinical Cancer Research (2)
  3. Annals of Oncology (1)
  4. British Journal of Cancer (1)
  5. JCO Precision Oncology (1)
  6. Journal of Thoracic Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (4)
  2. American Association for Cancer Research (2)
  3. Nature Publishing Group (2)
  4. Elsevier Inc. (1)
  5. Nature Research (1)
  6. Oxford University Press (1)

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immune biomarkers and response to checkpoint inhibition of BRAF(V600) and BRAF non-V600 altered lung cancers
    Journal Article

    Murciano-Goroff, Y. R.; Pak, T.; Mondaca, S.; Flynn, J. R.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Plodkowski, A. J.; Wu, S. L.; Kris, M. G.; more...
    British Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Clinical characteristics and anti-PD-(L)1 treatment outcomes of KRAS-G12C mutant lung cancer compared to other molecular subtypes of KRAS-mutant lung cancer
    Meeting Abstract

    Arbour, K. C.; Rizvi, H.; Plodkowski, A. J.; Halpenny, D.; Hellmann, M. D.; Heller, G.; Knezevic, A.; Yu, H. A.; Ladanyi, M.; Kris, M. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Molecular characteristics, immunophenotype, and immune checkpoint inhibitor response in BRAF non-V600 mutant lung cancers
    Meeting Abstract

    Offin, M.; Pak, T.; Mondaca, S.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Wu, S.; Kris, M.; Paik, P.; Riely, G.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
    Journal Article

    Hastings, K.; Yu, H. A.; Wei, W.; Sanchez-Vega, F.; DeVeaux, M.; Choi, J.; Rizvi, H.; Lisberg, A.; Truini, A.; Lydon, C. A.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • High yield of RNA sequencing for targetable kinase fusions in lung adenocarcinomas with no mitogenic driver alteration detected by DNA sequencing and low tumor mutation burden
    Journal Article

    Benayed, R.; Offin, M.; Mullaney, K.; Sukhadia, P.; Rios, K.; Desmeules, P.; Ptashkin, R.; Won, H.; Chang, J.; Halpenny, D.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Immunophenotype and response to immunotherapy of RET-rearranged lung cancers
    Journal Article

    Offin, M.; Guo, R.; Wu, S. L.; Sabari, J.; Land, J. D.; Ni, A.; Montecalvo, J.; Halpenny, D. F.; Buie, L. W.; Pak, T.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Clinical and molecular features predicting long-term response (LTR) to anti-PD-(L)1 based therapy in patients with NSCLC
    Meeting Abstract

    Rizvi, H.; Plodkowski, A. J.; Tenet, M.; Halpenny, D.; Long, N.; Sauter, J. L.; Sanchez-Vega, F.; Chatila, W. K.; Schultz, N.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Molecular determinants of response to anti-programmed cell death (PD)-1 and anti-programmed death-ligand 1 (PD-L1) blockade in patients with non-small-cell lung cancer profiled with targeted next-generation sequencing
    Journal Article

    Rizvi, H.; Sanchez-Vega, F.; La, K.; Chatila, W.; Jonsson, P.; Halpenny, D.; Plodkowski, A.; Long, N.; Sauter, J. L.; Rekhtman, N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Next-generation sequencing of pulmonary large cell neuroendocrine carcinoma reveals small cell carcinoma-like and non-small cell carcinoma-like subsets
    Journal Article

    Rekhtman, N.; Pietanza, M. C.; Hellmann, M. D.; Naidoo, J.; Arora, A.; Won, H.; Halpenny, D. F.; Wang, H.; Tian, S. K.; Litvak, A. M.; more...
    Clinical Cancer Research (2016)

    Fulltext@MSK | Save
  • Next-generation sequencing of pulmonary large cell neuroendocrine carcinoma reveals clinically-relevant subsets with small cell carcinoma-like and non-small cell carcinoma-like molecular profiles
    Meeting Abstract

    Rekhtman, N.; Naidoo, J.; Pietanza, M.; Hellmann, M. D.; Arora, A.; Shen, R. L.; Halpenny, D. F.; Won, H.; Berger, M. F.; Tian, S. Z.; more...
    Modern Pathology (2016)

    Fulltext@MSK | Save